View full size
- Analiza kwasów nukleinowych
- Analiza białek
- Odczynniki biochemiczne
- Enzymy
- Edytowanie genów
- Klonowanie
- Diagnostyka kliniczna
- Human Identification STR kits
- Sprzęt laboratoryjny
- Oprogramowanie
- A&A Biotechnology
Aktualności
-
1st Czechoslovak Congress of Medical Genetics 2025
In the spring, we will participate in the 1st Czechoslovak Congress of Medical Genetics, which will take place from April 2–4, 2025, at the Cultural and Congress Center Elektra in the spa town of Luha...
Czytaj więcej -
RANK 2025
Visit us at the 19th edition of the RANK 2025 conference, which will take place on March 19th and 20th at the Zlatá Štika Hotel in Pardubice. The conference is organized by the Czech Society of Clinic...
Czytaj więcej -
Kapras Day 2025
We would like to invite you to the 23rd Kapras Day on the topic of "Clinical Genetics," which will take place on Wednesday, February 26, 2025, in the Congress Hall of Hotel Olšanka in Prague. We loo...
Czytaj więcej
View full size
Description
Human Nicotinamide Phosphoribosyltransferase (NAMPT) catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, one step in the biosynthesis of nicotinamide adenine dinucleotide. The protein belongs to the nicotinic acid phosphoribosyltransferase (NAPRTase) family and is thought to be involved in many important biological processes, including metabolism, stress response and aging. This gene has a pseudogene on chromosome 10.
Source
E. coli
UniProt ID
P43490
Molecule Weight
The mature recombinant human NAMPT is a 52 kDa protein (1-491aa) with a His-tag at the N-terminus.
Purity
> 95 % as determined by SDS-PAGE
Endotoxin
< 0.1 EU per μg of the protein as determined by the LAL method
Storage
-80 Avoid repeated freeze-thaw cycles.
Koszyk
produkt
(pusty)
